• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Capsid and RNA stabilisation of the oral polio vaccine.

作者信息

Verheyden B, Andries K, Rombaut B

机构信息

Department of Microbiology and Hygiene, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090, Brussels, Belgium.

出版信息

Vaccine. 2001 Feb 28;19(15-16):1899-905. doi: 10.1016/s0264-410x(00)00442-4.

DOI:10.1016/s0264-410x(00)00442-4
PMID:11228359
Abstract

The oral polio vaccine is the least stable vaccine of the common childhood vaccines. Two different inactivation mechanisms are responsible for the thermolability of the vaccine, i.e. denaturation of the viral capsid and degradation of the viral RNA within the capsid. Pirodavir, a capsid-binding compound, inhibits the viral capsid thermodenaturation. In this paper we show that deuterium oxide is able to stabilise the viral RNA against thermodegradation and that a combination of pirodavir and deuterium oxide leads to an additive effect indicating that both stabilisers work indeed on different inactivation mechanisms. Furthermore, it is shown that the variation in thermostability of the different vaccine strains is due to the different thermostability of their capsids.

摘要

相似文献

1
Capsid and RNA stabilisation of the oral polio vaccine.
Vaccine. 2001 Feb 28;19(15-16):1899-905. doi: 10.1016/s0264-410x(00)00442-4.
2
Stabilisation of poliovirus with pirodavir.用吡罗达韦稳定脊髓灰质炎病毒。
Dev Biol Stand. 1996;87:173-80.
3
The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine.用重水替代水可显著提高口服脊髓灰质炎疫苗的热稳定性。
Dev Biol Stand. 1996;87:161-6.
4
The thermostability of vaccines. Technologies for improving the thermostability of the oral poliovirus vaccine.疫苗的热稳定性。提高口服脊髓灰质炎疫苗热稳定性的技术。
Int J Technol Assess Health Care. 1994 Winter;10(1):177-84. doi: 10.1017/s0266462300014100.
5
Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.口服脊髓灰质炎疫苗的热灭活:RNA和蛋白质灭活的作用
J Virol. 1994 Oct;68(10):6454-7. doi: 10.1128/JVI.68.10.6454-6457.1994.
6
Water isotope effect on the thermostability of a polio viral RNA hairpin: A metadynamics study.水同位素对脊髓灰质炎病毒 RNA 发夹结构热稳定性的影响:一项分子动力学研究。
J Chem Phys. 2017 Apr 28;146(16):165104. doi: 10.1063/1.4982049.
7
Regulatory considerations for new stabilised poliovaccines.
Dev Biol Stand. 1996;87:181-9.
8
Studies on the loss of infectivity of live type 3 poliovaccine on storage.
Biologicals. 1998 Mar;26(1):17-23. doi: 10.1006/biol.1997.0118.
9
Thermostability of poliovirus and measles vaccines.脊髓灰质炎病毒和麻疹疫苗的热稳定性
Dev Biol Stand. 1996;87:155-60.
10
Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.衣壳结合化合物对口服脊髓灰质炎疫苗感染性和抗原性稳定性的差异
J Virol. 1994 May;68(5):3397-400. doi: 10.1128/JVI.68.5.3397-3400.1994.

引用本文的文献

1
Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication.用于降低成本、提高覆盖率并促进脊髓灰质炎根除的灭活脊髓灰质炎疫苗的当前和下一代配方策略。
Hum Vaccin Immunother. 2022 Dec 30;18(7):2154100. doi: 10.1080/21645515.2022.2154100. Epub 2022 Dec 28.
2
Impact of Deuteration on the Assembly Kinetics of Transthyretin Monitored by Native Mass Spectrometry and Implications for Amyloidoses.氘代对天然质谱监测的转甲状腺素蛋白组装动力学的影响及其对淀粉样变性病的影响。
Angew Chem Int Ed Engl. 2016 Aug 1;55(32):9292-6. doi: 10.1002/anie.201602747. Epub 2016 Jun 17.
3
Use of heavy water (D2O) in developing thermostable recombinant p26 protein based enzyme-linked immunosorbent assay for serodiagnosis of equine infectious anemia virus infection.
利用重水(D2O)开发基于热稳定重组p26蛋白的酶联免疫吸附测定法用于马传染性贫血病毒感染的血清学诊断。
ScientificWorldJournal. 2014 Jan 9;2014:620906. doi: 10.1155/2014/620906. eCollection 2014.
4
Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectiveness.用于甲型和乙型流感的神经氨酸酶抑制剂:抗病毒药物需免受不利条件影响以保持有效性。
BMJ. 2003 Jul 12;327(7406):105-6. doi: 10.1136/bmj.327.7406.105-c.
5
Adequate quality of HIV drugs must be ensured.必须确保艾滋病毒药物的质量合格。
BMJ. 2002 Jan 26;324(7331):235-6. doi: 10.1136/bmj.324.7331.235b.